![Jaisim Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaisim Shah
Directeur Général chez
Scilex Pharmaceuticals, Inc.
Fortune : 75 054 $ au 31/05/2026
Profil
Jaisim Shah is President, Chief Executive Officer & Director at Scilex Pharmaceuticals, Inc. since 2016.
Former positions include President, Chief Executive Officer & Director at Semnur, Inc. from 2013 to 2019 and at Semnur Pharmaceuticals, Inc. from 2025 to 2026.
Director roles were held at Acucela, Inc., Celularity, Inc. (2017–2021), Scilex Holding Co. (2025), Scilex, Inc. (2024–2025), and Sorrento Therapeutics, Inc. (2014–2023).
Other former roles include Vice President-Global Marketing at Bristol Myers Squibb Co. (1997–2000), Chief Business Officer & Senior Vice President at LadRx Corp., Senior VP-Marketing & Medical Affairs at Protein Design Labs, Inc. (2000–2006), Chief Business Officer at Pulmatrix Operating Co., Inc., President at Azelon Pharmaceuticals, Inc., Chief Business Officer & Senior Vice President at Abbott Biotherapeutics Corp.
(2008–2009), Chief Business Officer & Senior Vice President at PDL BioPharma, Inc. (2000–2008), and Chief Business Officer & Senior Vice President at Elevation Pharmaceuticals, Inc. (2011–2012).
Education includes graduate studies at the University of Akron and an MBA from the University of Oklahoma.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/04/2026 | 8 433 ( 0,1 % ) | 75 054 $ | 31/05/2026 | |
-.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jaisim Shah
| Sociétés | Poste | Début |
|---|---|---|
Scilex Pharmaceuticals, Inc.
 Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Directeur Général | - |
Anciens postes connus de Jaisim Shah
| Sociétés | Poste | Fin |
|---|---|---|
| SCILEX HOLDING COMPANY | Directeur Général | 17/08/2025 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Directeur Général | 01/08/2024 |
| SORRENTO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2023 |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Directeur/Membre du Conseil | 01/07/2021 |
Formation de Jaisim Shah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
LadRx Corp.
 LadRx Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development oncology company | Health Technology |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs for the treatment of osteoporosis | Health Technology |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Semnur, Inc.
 Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Health Technology |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oklahoma
 University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Elevation Pharmaceuticals, Inc.
 Elevation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures aerosol drug products | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Commercial Services |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
